Over 110 prospective Coronavirus vaccine projects are currently in progress in an attempt to cure the COVID-19. The coronavirus spread from a wet market in the Chinese city of Wuhan in December 2019. Some of these projects have reached the clinical trial phase. Others, however, have shown little less than favorable results.
The novel Coronavirus has, in a span of 4 months, infected close to 5 million around the globe. South America is now the newest epicenter of the viral infection.
Coronavirus Vaccine: An ETA
Leading researchers are of the opinion that people may have to wait another 14-18 months before a successful vaccine formulation is available. The Indian vaccine is floating in the same boat. Experts revealed that the vaccine is still in the nascent stage. Any conclusive development will take a while.
The British health secretary Matt Hancock said during a briefing that he hopes ‘everybody would have the vaccine’, if and when a coronavirus shot is rolled out, and did not rule out making it mandatory for every citizen.#CoronaVirusUpdates #coronavirusvaccine pic.twitter.com/LDvsveV0sU
— 28 Days Later (@VGKnightinArmor) May 23, 2020
Coronavirus Vaccine: Front Runners
- Moderna’s RNA Vaccine
Moderna’s RNA Coronavirus Vaccine is the top frontrunner. It will enter the second phase of clinical tests in July 2020. Stage 1 of clinical trials had reported promising results on 8 candidates who were able to develop protective antibodies to fight the Coronavirus. The vaccine also had a positive effects on the immunity.
— Shirley Henderson (@H5_Shirley) May 19, 2020
- CanSino Biologics Inc Vaccine
A strong fresh contender in the global race to the vaccine has emerged. CanSino Biologics Inc, China is the company developing this vaccine. A specific virus mutation by the name Ad5 was used in the formulation of this vaccine.
- AstraZeneca Plc Vaccine by Oxford University
One of the most looked forward to vaccines is AstraZeneca Plc Vaccine. A joint collaboration of Oxford University and AstraZeneca Plc is working towards this vaccine. The trials have begun with standardized animal testing. Unfortunately, concerns regarding the vaccine’s failure in preventing the infection spread have surfaced.